This page shows the latest difficult-to-treat cancers news and features for those working in and with pharma, biotech and healthcare.
a promising new modality to Regeneron's toolkit of potential approaches for difficult-to-treat cancers. ... We look forward to welcoming the Checkmate team and their complementary scientific acumen to the Regeneron family.".
The site, situated in the US, is set to produce Kite’s FDA-approved CAR T-cell therapy used to treat blood cancers. ... strengthen our ability to meet the needs of people living with difficult-to-treat blood cancers,” said Christi Shaw, CEO of Kite.
dosed adenosine receptor antagonist, TT-702, for the treatment of patients with a range of difficult-to-treat cancers. ... treat cancers, which is why we are so delighted that we have successfully advanced TT-702 into human trials with Teon, safely
advanced or recurrent disease have limited options available to them once the disease progresses following platinum-based chemotherapy. ... The phase 3 Study 309/KEYNOTE-775 trial demonstrates the ongoing commitment that Eisai and Merck share in
deliver benefit to patients with some of the most difficult to treat cancers, including pancreatic, lung, colon and prostate.”. ... Gilead will also pay Arcus tiered royalties ranging from ‘the mid-teens to the low twenties’.
This bifunctional approach is thought to control tumour growth by potentially restoring and enhancing anti-tumour responses. ... In preclinical studies, bintrafusp alfa demonstrated activity both as a monotherapy and in combination with chemotherapy,
More from news
Approximately 1 fully matching, plus 22 partially matching documents found.
Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with ... Visit AmgenOncology.com to learn more about the
What is the central focus of Crescendo’s research? The company is focused on T-cell enhancement to develop new ways to treat difficult cancer types. ... success – or to make advances in those cancers that are still difficult to treat in this way.
Radiosurgery has greatest application in patients with difficult-to-treat cancers such as brain tumours. ... This was a tough ask of Pegasus as our technology is highly complex and it can be difficult to get journalists to understand its potential, let
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...